References
KDIGO AKI Workgorup (2012) Kidney disease: improving global outcomes (KDIGO) clinical practice guideline for acute kidney injury. Kidney Int 2:1–141
Kellum JA, Sileanu FE, Murugan R et al (2015) Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol 26:2231–2238. doi:10.1681/ASN.2014070724
Kaddourah A, Basu RK, Bagshaw SM et al (2016) Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med. doi:10.1056/NEJMoa1611391
Liu KD, Vijayan A, Rosner MH et al (2016) Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study. Nephrol Dial Transpl. doi:10.1093/ndt/gfw238
Fuhrman DY, Kellum JA (2016) Biomarkers for diagnosis, prognosis and intervention in acute kidney injury. Contrib Nephrol 187:47–54. doi:10.1159/000442364
Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25. doi:10.1186/cc12503
Koyner JL, Shaw AD, Chawla LS et al (2015) Tissue inhibitor metalloproteinase-2 (TIMP-2) IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 26:1747–1754. doi:10.1681/ASN.2014060556
Kellum JA, Sileanu FE, Bihorac A et al (2016) Recovery after acute kidney injury. Am J Respir Crit Care Med. doi:10.1164/rccm.201604-0799OC
Chawla LS, Eggers PW, Star RA, Kimmel PL (2014) Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371:58–66. doi:10.1056/NEJMra1214243
James MT, Dixon E, Roberts DJ et al (2014) Improving prevention, early recognition and management of acute kidney injury after major surgery: results of a planning meeting with multidisciplinary stakeholders. Can J Kidney Health Dis 1:20. doi:10.1186/s40697-014-0020-y
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
JAK reports consulting fees and/or grant support from Astute Medical, BioPorto, and Medibeacon; AZ reports consulting fees and grant support from Astute Medical; MKN reports consulting fees from Sphingotec.
Rights and permissions
About this article
Cite this article
Kellum, J.A., Zarbock, A. & Nadim, M.K. What endpoints should be used for clinical studies in acute kidney injury?. Intensive Care Med 43, 901–903 (2017). https://doi.org/10.1007/s00134-017-4732-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-017-4732-1